{"meshTagsMajor":["Induction Chemotherapy"],"meshTags":["Adult","Aged","Antineoplastic Combined Chemotherapy Protocols","Chemoradiotherapy","Chemotherapy, Adjuvant","Cisplatin","Female","Fluorouracil","Humans","Induction Chemotherapy","Middle Aged","Neoadjuvant Therapy","Retrospective Studies","Russia","Treatment Outcome","Uterine Cervical Neoplasms"],"meshMinor":["Adult","Aged","Antineoplastic Combined Chemotherapy Protocols","Chemoradiotherapy","Chemotherapy, Adjuvant","Cisplatin","Female","Fluorouracil","Humans","Middle Aged","Neoadjuvant Therapy","Retrospective Studies","Russia","Treatment Outcome","Uterine Cervical Neoplasms"],"publicationTypes":["English Abstract","Journal Article"],"abstract":"The main methods of treatment for cervical cancer are surgery, radiotherapy or their combination. During past two decades chemotherapy are increasingly being used not only in patients with disseminated forms of this disease but also in patients undergoing chemoradiotherapy or as induction therapy. Possibilities of adjuvant chemotherapy for cervical cancer are being studied. According to A.D.Kaprin and V.V. Starinskiy in 2013 in Russia, 32% of patients with newly diagnosed cervical cancer underwent only radiation therapy, 32%--combined or complex treatment, 27.3%--only surgery, and just 8.7%--chemoradiotherapy.","title":"[Induction chemotherapy for locally advanced cervical cancer].","pubmedId":"26087600"}